@openevidence.bsky.social
Reposted
The NCCN's Clinical Practice Guidelines in Oncology to be integrated into @openevidence.bsky.social's medical AI platform so clinicians can access trusted, evidence-based cancer care recommendations for decision-making support via natural language search.
➡️https://ow.ly/QqaK50Xr3w4
➡️https://ow.ly/QqaK50Xr3w4
November 13, 2025 at 6:15 PM
The NCCN's Clinical Practice Guidelines in Oncology to be integrated into @openevidence.bsky.social's medical AI platform so clinicians can access trusted, evidence-based cancer care recommendations for decision-making support via natural language search.
➡️https://ow.ly/QqaK50Xr3w4
➡️https://ow.ly/QqaK50Xr3w4
Reposted
New on The Tech Glow Up from #hlth2025 40% of doctors use it. Daily. 🩺🤖 @OpenEvidence = ChatGPT for clinicians, built by Harvard AI researchers who got tired of generic search
40M papers + 20K new studies/day = knowledge overload solved!
@openevidence.bsky.social
40M papers + 20K new studies/day = knowledge overload solved!
@openevidence.bsky.social
November 10, 2025 at 4:52 PM
New on The Tech Glow Up from #hlth2025 40% of doctors use it. Daily. 🩺🤖 @OpenEvidence = ChatGPT for clinicians, built by Harvard AI researchers who got tired of generic search
40M papers + 20K new studies/day = knowledge overload solved!
@openevidence.bsky.social
40M papers + 20K new studies/day = knowledge overload solved!
@openevidence.bsky.social
Reposted
@travizack.bsky.social and Varun from OE talk AI and the future of medical information on the STAT-AI podcast:
open.spotify.com/episode/121y...
open.spotify.com/episode/121y...
EP10 Travis Zack MD, PhD and Varun Mangalick BS, Open Evidence
STAT AI: An Emergency Medicine Podcast · Episode
open.spotify.com
February 17, 2025 at 4:11 AM
@travizack.bsky.social and Varun from OE talk AI and the future of medical information on the STAT-AI podcast:
open.spotify.com/episode/121y...
open.spotify.com/episode/121y...
Happy first day!
To all interns, residents, fellows, and new attendings.
We are building specialty specific learning communities at OE. If you are interested in joining peers and learning together with Openevidence, shoot us an email at [email protected]
To all interns, residents, fellows, and new attendings.
We are building specialty specific learning communities at OE. If you are interested in joining peers and learning together with Openevidence, shoot us an email at [email protected]
July 1, 2025 at 3:41 PM
Happy first day!
To all interns, residents, fellows, and new attendings.
We are building specialty specific learning communities at OE. If you are interested in joining peers and learning together with Openevidence, shoot us an email at [email protected]
To all interns, residents, fellows, and new attendings.
We are building specialty specific learning communities at OE. If you are interested in joining peers and learning together with Openevidence, shoot us an email at [email protected]
Dr. Atul Butte was laid to rest today. His large shoulders and larger vision have been foundational to all AI can and will accomplish in healthcare.
His family is requesting those interested to please consider supporting research on mpnst here: giving.ucsf.edu/fund/maligna...
His family is requesting those interested to please consider supporting research on mpnst here: giving.ucsf.edu/fund/maligna...
Your gift can ignite discovery and inspire cures
What are you passionate about? Unlocking the brain’s mysteries? Battling health inequity? Donate to UCSF today, and together we will build a healthier tomorrow.
giving.ucsf.edu
June 21, 2025 at 4:17 AM
Dr. Atul Butte was laid to rest today. His large shoulders and larger vision have been foundational to all AI can and will accomplish in healthcare.
His family is requesting those interested to please consider supporting research on mpnst here: giving.ucsf.edu/fund/maligna...
His family is requesting those interested to please consider supporting research on mpnst here: giving.ucsf.edu/fund/maligna...
Reposted
👋 Our editors are on-site at #ASCO25, Chicago.
We’re excited to be part of this gathering of global cancer experts—come & meet us.
‘Contact the Editor’ details below, in-thread 🧵 @ascocancer.bsky.social
We’re excited to be part of this gathering of global cancer experts—come & meet us.
‘Contact the Editor’ details below, in-thread 🧵 @ascocancer.bsky.social
May 31, 2025 at 4:28 PM
👋 Our editors are on-site at #ASCO25, Chicago.
We’re excited to be part of this gathering of global cancer experts—come & meet us.
‘Contact the Editor’ details below, in-thread 🧵 @ascocancer.bsky.social
We’re excited to be part of this gathering of global cancer experts—come & meet us.
‘Contact the Editor’ details below, in-thread 🧵 @ascocancer.bsky.social
Reposted
Hello from the City of Lakes! We’re thrilled to welcome thousands of members of the ob-gyn community to the 2025 Annual Clinical & Scientific Meeting. From the heart of the Midwest, we’re kicking off a weekend of connection, learning, and inspiration. Share the excitement using #ACOG2025!
May 15, 2025 at 10:01 PM
Hello from the City of Lakes! We’re thrilled to welcome thousands of members of the ob-gyn community to the 2025 Annual Clinical & Scientific Meeting. From the heart of the Midwest, we’re kicking off a weekend of connection, learning, and inspiration. Share the excitement using #ACOG2025!
Reposted
As for the safety, I asked @openevidence.bsky.social which is a chatbot trained on the professional medical literature. The current thinking is that it is not ready for primetime. www.openevidence.com/ask/2ca4fd30...
OpenEvidence
The leading medical information platform.
www.openevidence.com
May 13, 2025 at 1:00 AM
As for the safety, I asked @openevidence.bsky.social which is a chatbot trained on the professional medical literature. The current thinking is that it is not ready for primetime. www.openevidence.com/ask/2ca4fd30...
we are now offering free CME credits just by OE in yuour normal practice:
www.openevidence.com/announcement...
www.openevidence.com/announcement...
OpenEvidence - CME has arrived on OpenEvidence
CAMBRIDGE, MA, April 2, 2025 – We are thrilled to announce that CME is now available for free on OpenEvidence! Verified NPI users can now earn AMA PRA Category 1 Credits™.
www.openevidence.com
April 30, 2025 at 8:32 PM
we are now offering free CME credits just by OE in yuour normal practice:
www.openevidence.com/announcement...
www.openevidence.com/announcement...
Reposted
So thrilled to welcome this extraordinary group of 64 young physicians to @UCSF and @UCSFimresidency. A great day!
(UCPC=UCSF Health-based primary care program; SFGH=San Francisco General-based primary care; PSTP=physician-scientist training program) @UCSFIMChiefs @UCSFDOM
(UCPC=UCSF Health-based primary care program; SFGH=San Francisco General-based primary care; PSTP=physician-scientist training program) @UCSFIMChiefs @UCSFDOM
March 21, 2025 at 7:28 PM
So thrilled to welcome this extraordinary group of 64 young physicians to @UCSF and @UCSFimresidency. A great day!
(UCPC=UCSF Health-based primary care program; SFGH=San Francisco General-based primary care; PSTP=physician-scientist training program) @UCSFIMChiefs @UCSFDOM
(UCPC=UCSF Health-based primary care program; SFGH=San Francisco General-based primary care; PSTP=physician-scientist training program) @UCSFIMChiefs @UCSFDOM
@travizack.bsky.social and Varun from OE talk AI and the future of medical information on the STAT-AI podcast:
open.spotify.com/episode/121y...
open.spotify.com/episode/121y...
EP10 Travis Zack MD, PhD and Varun Mangalick BS, Open Evidence
STAT AI: An Emergency Medicine Podcast · Episode
open.spotify.com
February 17, 2025 at 4:11 AM
@travizack.bsky.social and Varun from OE talk AI and the future of medical information on the STAT-AI podcast:
open.spotify.com/episode/121y...
open.spotify.com/episode/121y...
February 15, 2025 at 1:26 AM
Some background on current limited TX options:
www.openevidence.com/ask/a94c01ac...
However, there is a recently opened clinical trial for this rare disease
clinicaltrials.gov/study/NCT061...
@jerryclee.bsky.social
www.openevidence.com/ask/a94c01ac...
However, there is a recently opened clinical trial for this rare disease
clinicaltrials.gov/study/NCT061...
@jerryclee.bsky.social
February 8, 2025 at 5:07 PM
Some background on current limited TX options:
www.openevidence.com/ask/a94c01ac...
However, there is a recently opened clinical trial for this rare disease
clinicaltrials.gov/study/NCT061...
@jerryclee.bsky.social
www.openevidence.com/ask/a94c01ac...
However, there is a recently opened clinical trial for this rare disease
clinicaltrials.gov/study/NCT061...
@jerryclee.bsky.social
Some mechanistic background:
www.openevidence.com/ask/07ad3d33...
www.openevidence.com/ask/07ad3d33...
February 7, 2025 at 11:33 PM
Some mechanistic background:
www.openevidence.com/ask/07ad3d33...
www.openevidence.com/ask/07ad3d33...
A short review of where we were at prior to this trial
www.openevidence.com/ask/1e95f6d9...
www.openevidence.com/ask/1e95f6d9...
February 5, 2025 at 3:43 AM
A short review of where we were at prior to this trial
www.openevidence.com/ask/1e95f6d9...
www.openevidence.com/ask/1e95f6d9...
Reposted
In a new phase 2 trial, researchers evaluated the efficacy of a gene-editing therapy, NTLA-2002, in preventing angioedema attacks in patients with hereditary angioedema. Full trial results and Plain Language Summary: nej.md/4heR7hT
#MedSky #Oncology
#MedSky #Oncology
February 4, 2025 at 8:31 PM
In a new phase 2 trial, researchers evaluated the efficacy of a gene-editing therapy, NTLA-2002, in preventing angioedema attacks in patients with hereditary angioedema. Full trial results and Plain Language Summary: nej.md/4heR7hT
#MedSky #Oncology
#MedSky #Oncology
February 5, 2025 at 2:34 AM
Reposted
As a primary care doctor & clinical informatician, I love using @openevidence.bsky.social during my clinic visits to review latest guidelines with patients & sources.
I strongly believe this practice helps build stronger therapeutic relationship with the doctor + AI assisted CDS. #CI=AI
I strongly believe this practice helps build stronger therapeutic relationship with the doctor + AI assisted CDS. #CI=AI
February 4, 2025 at 8:10 PM
As a primary care doctor & clinical informatician, I love using @openevidence.bsky.social during my clinic visits to review latest guidelines with patients & sources.
I strongly believe this practice helps build stronger therapeutic relationship with the doctor + AI assisted CDS. #CI=AI
I strongly believe this practice helps build stronger therapeutic relationship with the doctor + AI assisted CDS. #CI=AI
Other prior trials looking at the pros and cons of bridging AC peri-procedures
www.openevidence.com/ask/67491f3f...
www.openevidence.com/ask/67491f3f...
February 4, 2025 at 5:56 AM
Other prior trials looking at the pros and cons of bridging AC peri-procedures
www.openevidence.com/ask/67491f3f...
www.openevidence.com/ask/67491f3f...
We do keep our index updated daily so the most recent cdc pubs and mmwr will continue to be available for answers even if removed from CDC website
Worth reading one of the comments to my original post -- Dr. John Brooks, who worked at CDC for decades, has found that they are updating data on the site even after the MMWR stopped its publication.
A reason to be hopeful (I hope ...)
A reason to be hopeful (I hope ...)
The communications pause for federal health agencies meant that the CDC couldn't publish the MMWR this week -- the first time in the publication's 60+ year history this has happened.
Unhappy about this! Getting good data published on infectious threats is critical, especially as H5N1 looms. #IDSky
Unhappy about this! Getting good data published on infectious threats is critical, especially as H5N1 looms. #IDSky
February 1, 2025 at 10:49 PM
We do keep our index updated daily so the most recent cdc pubs and mmwr will continue to be available for answers even if removed from CDC website
Reposted
These A.I. models are rapidly changing life science.
A brief, open-access review of the remarkable progress in @science.org this week
www.science.org/doi/10.1126/...
A brief, open-access review of the remarkable progress in @science.org this week
www.science.org/doi/10.1126/...
Learning the language of life with AI
In 2021, a year before ChatGPT took the world by storm amid the excitement about generative artificial intelligence (AI), AlphaFold 2 cracked the 50-year-old protein-folding problem, predicting three-...
www.science.org
February 1, 2025 at 6:51 PM
These A.I. models are rapidly changing life science.
A brief, open-access review of the remarkable progress in @science.org this week
www.science.org/doi/10.1126/...
A brief, open-access review of the remarkable progress in @science.org this week
www.science.org/doi/10.1126/...
For whom it make concern, with recent disruptions to CDC published information, we keep our index of this information updated daily, so will always have the most updated recommendations
February 1, 2025 at 10:39 PM
For whom it make concern, with recent disruptions to CDC published information, we keep our index of this information updated daily, so will always have the most updated recommendations
Reposted
Nature research paper: Expanding the human gut microbiome atlas of Africa
https://go.nature.com/42x1t7S
https://go.nature.com/42x1t7S
Expanding the human gut microbiome atlas of Africa - Nature
A cross-sectional study from four African countries shows the importance of investigating the gut microbiome in previously under-represented populations and provides a framework for equitable microbiome research.
go.nature.com
January 30, 2025 at 3:09 PM
Nature research paper: Expanding the human gut microbiome atlas of Africa
https://go.nature.com/42x1t7S
https://go.nature.com/42x1t7S
Reposted
Painful, chronic peripheral neuropathy from cancer chemotherapy is common, especially from platinum-based drugs and taxanes, as reported today in a meta-analysis of 77 studies from 28 countries
January 29, 2025 at 12:07 AM
Painful, chronic peripheral neuropathy from cancer chemotherapy is common, especially from platinum-based drugs and taxanes, as reported today in a meta-analysis of 77 studies from 28 countries